Australia

Australia Introduction

Australia operates a national medical cannabis system via the Therapeutic Goods Administration (TGA), with access primarily through Special Access Scheme (SAS-B) and Authorised Prescriber (AP) pathways. Recreational cannabis is illegal at the federal level, though the Australian Capital Territory (ACT) permits limited home cultivation and private possession (no retail). Industrial hemp is licensed at state/territory level (typically ≤1% THC in field), and hemp seed foods have been legal nationally since 2017. Low-dose CBD was down-scheduled to Schedule 3 (pharmacist-only) in principle, but no products are yet registered for true OTC sale; CBD remains prescription-only in practice. From 1 July 2023, psilocybin (for TRD) and MDMA (for PTSD) can be prescribed only by Authorised Psychiatrists under tight controls.

---

Cannabis & Wellness Regulation Overview

Recreational Cannabis (Adult Use)

Status: Not legalized nationwide.

• ACT permits adults to possess up to 50 g dry (or 150 g fresh) and grow up to 2 plants per adult (max 4 per household) for personal/private use; sale/supply remains illegal.
• All other states/territories: possession and supply remain offences (some caution/diversion schemes exist).

Medical Cannabis

Status: Legal via TGA SAS-B/AP pathways; some registered products.

• Prescribers access unapproved products via SAS-B or become Authorised Prescribers; prescribing now by active-ingredient categories (e.g., high THC, CBD-only).
• Quality standard TGO 93 applies; products must meet GMP and specification requirements.
• Registered medicines include nabiximols (Sativex®) and cannabidiol (Epidyolex®); most other products are unapproved but lawful via SAS/AP.

Hemp Definition & Industrial Use

Status: Licensed cultivation; ≤1% THC threshold (state/territory laws).

• Industrial hemp for fiber/seed is permitted with state licences; thresholds and compliance testing apply.
• Hemp seed foods (dehulled seed, seed oil, protein, flour) have been legal since 2017 under FSANZ; THC residue limits apply; no cannabinoids may be added as food ingredients.

CBD Products

Status: Prescription-only in practice.

• Schedule 3 OTC category (≤150 mg/day CBD, ≥98% CBD, very low other cannabinoids) exists in principle, but no CBD S3 products are on the ARTG yet, so pharmacies cannot sell OTC CBD.
• Prescription CBD (S4) and THC-containing products (S8) supplied via SAS/AP; advertising to consumers is restricted under the Therapeutic Goods Act/Code.
• CBD in foods is not permitted; import of CBD products without permits is seized by ABF.

Cosmetics & Artisanal Products

Status: Restricted to non-cannabinoid hemp derivatives.

• Hemp seed oil (non-cannabinoid) is acceptable in cosmetics (AICIS + cosmetic rules).
• Cannabinoid extracts (e.g., CBD, “hemp oil” from flowers/leaves) are considered drugs and not permitted in cosmetics unless approved as therapeutic goods (which then are not cosmetics).

Functional Mushrooms & Adaptogens

Status: Generally permitted under food/supplement law.

• Reishi, lion’s mane, cordyceps, chaga, etc. can be sold as foods/supplements subject to FSANZ standards and claims controls.
• Novel ingredients/extracts may need separate assessment.

Psilocybin / Psychedelics

Status: Controlled clinical prescribing only (from 1 July 2023).

• Authorised Psychiatrists may prescribe psilocybin (for treatment-resistant depression) and MDMA (for PTSD) under the Authorised Prescriber framework; outside this, substances remain prohibited.
• Strict clinical governance, compounding/dispensing controls, and reporting apply.

---

Operating Guidance (Hemp Vegan)

Wellness-Driven Coffee & Retail

Australia rewards a compliance-first launch:

• Choose your space: cafés/wellness hubs focused on coffee, teas, superfoods, functional mushrooms, and hemp seed foods/cosmetics.
• Plug into the ecosystem: medical education with prescribers/pharmacies, robust lab testing (TGO 93 specs), and AICIS cosmetic registrations.
• Grow with support: SOPs for claims, age-gating, adverse-event handling, and import documentation.

Clinical Tools & AI

• Prescriber flows aligned with TGA SAS-B/AP; active-ingredient category selection, dosing, interactions, and pharmacovigilance prompts.
• Patient materials in English; consent templates and driving/impairment advisories.

---

Marketing, Claims & Compliance

Advertising & Claims

• No therapeutic claims unless a product is a registered medicine (ARTG) or lawful unapproved medicine within Code rules.
• CBD ingestibles cannot be marketed as foods; cosmetics must avoid therapeutic positioning.
• Educational, structure/function language is preferred for wellness lines.

Packaging & Labeling

• Medical cannabis: pharma-grade labeling, cannabinoid specs, batch/expiry, Rx restrictions.
• Hemp foods: ingredient list, allergen disclosure, nutrition facts; THC residue compliance.
• Cosmetics: INCI, Responsible Person/supplier, batch, expiry/PAO; evidence that no cannabinoids are present.

---

Taxes, Import & Duties

• GST: 10%.
• Imports of cannabis/CBD require permits; ABF seizes non-compliant items.
• Medical cannabis imports must follow ODC/TGA rules and INCB controls; hemp foods/cosmetics follow standard customs and food/cosmetic law.

---

Risks & Practical Notes

• Recreational retail remains illegal nationwide (ACT exception is private/home grow only).
• S3 CBD remains theoretical until an ARTG product is registered — plan for Rx-only CBD.
• Cosmetics with CBD/‘hemp oil’ are not permitted; stick to hemp seed oil.
• Strategy: lead with functional mushrooms and hemp seed lines; build clinical partnerships for medical cannabis; monitor S3 CBD and state hemp updates.

---

FAQ (Hemp Vegan)

Can pharmacies sell OTC CBD now?

Not yet. No Schedule 3 CBD products are on the ARTG, so CBD remains prescription-only in practice.

Is adult-use cannabis legal anywhere in Australia?

No retail. Only the ACT allows limited home grow/private possession; sale remains illegal.

Can I put CBD in a cosmetic?

No. CBD/cannabinoid extracts are treated as drugs and not permitted in cosmetics. Hemp seed oil (no cannabinoids) is fine.

---

Sources & Review Log

_Last reviewed_: 2025-08-23

• TGA — Medicinal cannabis access & usage data; active-ingredient categories; TGO 93 quality. :contentReference[oaicite:0]{index=0}
• TGA — Low-dose CBD S3 (OTC) decision; no ARTG S3 products as of 2025. :contentReference[oaicite:1]{index=1}
• ACT personal cannabis rules (possession 50 g dry/150 g fresh; 2 plants per adult, max 4 per home). :contentReference[oaicite:2]{index=2}
• FSANZ — hemp seed foods legal since 2017; low-THC hemp food standards. :contentReference[oaicite:3]{index=3}
• Industrial hemp ≤1% THC licensing (state examples). :contentReference[oaicite:4]{index=4}
• TGA — Psilocybin/MDMA rescheduling (from 1 July 2023). :contentReference[oaicite:5]{index=5}
• ODC/ABF — cannabinoid ‘hemp oil’ not permitted for cosmetics; imports seized without permits. :contentReference[oaicite:6]{index=6}